Non-vascular Stents Market Size, Share, Growth and Industry Analysis Report, 2018 to 2025

The
global non-vascular stents market is anticipated to reach USD
1.4 billion by 2025, according to a new report by Grand View Research, Inc. The
market is expected to witness lucrative growth during the forecast period due
to technological advancements in the non-vascular stents and rise in adoption
of minimally invasive surgeries across the world.
Technological
advancements such as development of radioactive & biodegradable stents,
advanced stent designs & change in material composition, and newer stent
placement techniques, such as Endoscopic Ultrasound-guided (EUS) stenting, are
expected to help in growth of the non-vascular stents market over the forecast
period. Various materials such as metallic stents, made from alloys include
nitinol, silicone & nitinol, stainless steel, and
elgiloy(cobalt-chromium-nickel Alloy) and nonmetallic stents, made from synthetic
polymers such as resins, polyurethane,
and silicone, are used as per requirement as they offer different features.
Due to high
adoption of minimally invasive techniques, such as nonvascular stenting, by
healthcare professionals the market is expected to grow. This can be attributed
to the various advantages such as smaller incisions, rapid wound healing, and
reduced pain & surgical scars. Smaller incisions and surgical wounds result
in lesser complications, which significantly reduces the overall surgery cost.
Moreover, minimally invasive surgeries result in reduced hospital stay, which
ultimately lowers the risk of hospital-acquired infections in patients. This
helps reduce the overall healthcare expenditure of patients.
Further Key
Findings from the Study Suggest:
- The urological
stents segment held a lucrative market share in 2016 owing to worldwide
increase in demand for ureteral, and prostate stents, which can be
attributed to the surge in number of kidney transplants, ureteroscopy,
ureterorenoscopy, lithotripsy, and schistosomiasis procedures
- The gastrointestinal
stents segment is expected to register highest growth over the
forecast period owing to surge in the number of cases of gastrointestinal
cancer, such as cancer of the esophagus, stomach, gallbladder, small
intestine, pancreas, liver, bowel, and anus
- North America
is expected to dominate the market during the forecast period owing to the
local presence of major market players and robust healthcare
infrastructure coupled with high prevalence of gastrointestinal cancer in
the U.S. & Canada
- Some of the key
players in the market are Medtronic; C. R. Bard, Inc.; Boston Scientific
Corporation; ELLA - CS, s.r.o.; CONMED Corporation; HOBBS MEDICAL INC;
Cook Medical; Taewoong Medical Co., Ltd.; Synchron Med Inc.; and Glaukos
Corporation
Grand View
Research has segmented the global non-vascular stents market on the basis of
product and region:
Product Outlook
(Revenue, USD Million, 2014 - 2025)
- Gastrointestinal
Stents
- Biliary
- Duodenal
- Colonic
- Pancreatic
- Esophageal
Stets
- Pulmonary
(Airway) Stents
- Silicone
Airway
- Metallic
Airway
- Urological
Stents
- Others
Regional Outlook
(Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East and
Africa (MEA)
- South Africa
Access full
research report on global non-vascular
stents market:
http://www.grandviewresearch.com/industry-analysis/non-vascular-stents-market
Post Your Ad Here
Comments